LATEST UPDATES » Vol 24, No. 09, September 2020 – 3D Technology: Additive Manufacturing Applications and Prospects       » Results of CD30 CAR-T Cell Therapy Trial Shows Promise for Hodgkin Lymphoma Patients       » Emerging Technologies and Innovations amid a Global Pandemic       » Monitoring COVID-19 Patients with AI-powered Platform       » Singapore Researchers Devise a Rapid COVID-19 Test Kit for the Detection of Neutralising Antibodies (NAbs) Against SARS-CoV-2       » Novel Ventilator Conceptualized by Singapore Clinicians Provides Efficient and Personalized Breathing Support for COVID-19 patients      
Vol 23, No. 11, November 2019   |   Issue PDF view/purchase
Blocking production of a protein to reduce weight
A team of scientists from the Genomics Research Centre, Academia Sinica demonstrated the enzymatic activity of Naa10p on fat tissue

Diet-induced obesity (DIO) is a serious public health issue worldwide, increasing the risk of various chronic diseases such as Type 2 Diabetes, cardiovascular disease, stroke, and some cancers.

In a study published in the Journal Mol Cell by a team led by Dr. Li-Jung Juan of the Genomics Research Centre, Academia Sinica showed that the mammalian N-α-acetyltransferase 10 protein (Naa10p) enzyme activity may provide a potential strategy for treating obesity.

Naa10p physiologically functions in the early development of an infant. Mutations in human Naa10p have been associated with severe developmental defects including Ogden syndrome where patients typically rarely survive beyond the age of one and a half years.

The study reports that inactivation of Naa10p gene in mice prevents high fat diet-induced obesity, promotes formation of beige fats, and increases energy expenditure and thermogenesis. Specifically switching off adipose Naa10p gene further confirmed the role Naa10p in preventing formation of fat.

In their experiments, the adipose-specific Naa10p gene deactivated in adult mice not only shows no signs of developmental defects, but also has no symptoms of diet-induced obesity. Inhibiting Naa10p enzymatic activity in adult adipose tissues might just be a potential new cure for obesity.

The study was primarily corresponded by Dr. Li-Jung Juan. Most experiments were carried out by the first and co-corresponding author Dr. Chen-Cheng Lee, an Academia Sinica Postdoctoral Scholar at Juan Lab, with critical help from Yi-Chun Shih, Ming-Lun Kang and Ramanan Devaraj from the same lab. Collaborators include Dr. Yi-Cheng Chang and Lee-Ming Chuang from Department of Internal Medicine, National Taiwan University Hospital.

news PharmaSources Launches the Export-Driven Event CPhI & P-MEC China E-Trade Season
news PharmaSources.com to Help Propel the Chinese API Export Business with E-Trade Session CPhI China Top API Exporters & Products
news Singapore Biomedical Company Appointed as a Certified Service Provider by 10x Genomics
news Proteona Honoured with "one to watch" Prize in the Inaugural Spinoff Prize by Nature Research and Merck Grou

About Us
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
Copyright© 2020 World Scientific Publishing Co Pte Ltd  •  Privacy Policy